A recent study highlights the combined impact of common and rare genetic variants on the risk of inflammatory bowel disease in patients with immunodeficiency. This research could inform future genetic screening and risk assessment strategies.
additive effects of common and rare genetic variants on inflammatory bowel disease risk in a cohort with immunodeficiency
Original title: “Additive effects of common and rare genetic variants on inflammatory bowel disease risk in a cohort with immunodeficiency.”